These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4384172)

  • 1. [Use of dantromin in geriatrics].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1967 Apr; 22(17):641-3. PubMed ID: 4384172
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of pemoline and magnesium hydroxide as a mild stimulant in geriatric patients.
    Goldstein BJ; Braunstein J
    Curr Ther Res Clin Exp; 1968 Sep; 10(9):457-60. PubMed ID: 4386689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the clinical effect of short-term administration of Pondex, methylphenidate, and placebos in neuroses].
    Bojanovský J; Hánysová Z; Bouchal M; Náhunek K; Vanýsek J
    Act Nerv Super (Praha); 1967 Nov; 9(4):373. PubMed ID: 4388629
    [No Abstract]   [Full Text] [Related]  

  • 4. [New orientation in the pharmacological management of mental retardation].
    De Cándenas V
    Rev Clin Esp; 1969 Jan; 112(2):183-92. PubMed ID: 4388803
    [No Abstract]   [Full Text] [Related]  

  • 5. [Deadyn: treatment of behavior disorders].
    Dall'Oglio GN
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Apr; 91(2):576-82. PubMed ID: 4384083
    [No Abstract]   [Full Text] [Related]  

  • 6. A new anti-fatigue agent in general practice.
    Meadley RG
    Practitioner; 1965 Nov; 195(169):680-3. PubMed ID: 4378985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of the effect of the short-term administration of Pondex, methylphenidate, and placebo by various pshychological tests].
    Sindelárová M; Bojanovský J
    Act Nerv Super (Praha); 1967 Nov; 9(4):374. PubMed ID: 4388630
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of Pondex, methylphenidate and placebo during short term administration and the effect on serum potassium, calcium and sodium levels in neurotic patients].
    Bojanovský J; Hánysová Z
    Act Nerv Super (Praha); 1967 Nov; 9(4):375-6. PubMed ID: 4388631
    [No Abstract]   [Full Text] [Related]  

  • 9. Magnesium pemoline and job performance in mentally handicapped workers.
    Greenblatt DJ; DiMascio A; Messier M; Stotsky B
    Clin Pharmacol Ther; 1969; 10(4):530-3. PubMed ID: 4389444
    [No Abstract]   [Full Text] [Related]  

  • 10. Influences of cylert upon memory changes with ECT.
    Small IF; Sharpley P; Small JG
    Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991
    [No Abstract]   [Full Text] [Related]  

  • 11. Pemoline augmentation for resistant depression.
    Benazzi F
    J Psychiatry Neurosci; 1997 Jan; 22(1):71. PubMed ID: 9002395
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of azoxodon in obstetric and gynecologic praxis].
    Rembez IM; Sas IuV; Nahorna VF; Iampol's'ka VI
    Pediatr Akus Ginekol; 1968 Jan; 1():55-7. PubMed ID: 4386036
    [No Abstract]   [Full Text] [Related]  

  • 13. Photic responses in "minimal brain dysfunction".
    Milstein V; Small JG
    Dis Nerv Syst; 1974 Aug; 35(8):355-7. PubMed ID: 17894071
    [No Abstract]   [Full Text] [Related]  

  • 14. Pemoline (Cylert): market withdrawal.
    Hogan V
    CMAJ; 2000 Jan; 162(1):106, 110. PubMed ID: 11216184
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with a new drug combination in geriatric treatment].
    Haydn G
    Med Welt; 1967 Oct; 43():2595-9. PubMed ID: 4388304
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental study of a new psycho-stimulating agent: magnesium pemoline].
    Faglioni P; De Renzi E; Pieczuro A
    Sist Nerv; 1966; 18(3):165-9. PubMed ID: 4381006
    [No Abstract]   [Full Text] [Related]  

  • 17. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
    Nierenberg AA; Dougherty D; Rosenbaum JF
    J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compounds related to pemoline. 2-amino-5-aryl-4-oxo-2-oxazolines.
    Lindberg UH; Pedersen J
    Acta Pharm Suec; 1968 Feb; 5(1):15-22. PubMed ID: 4386169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Attention deficit hyperactivity disorder in children].
    Bervoets L
    J Pharm Belg; 2002; 57(2):25-32. PubMed ID: 12053824
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.
    Morrato EH; Staffa JA
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):104-12. PubMed ID: 16821248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.